The social and economic cost of sleep disorders
| Autor: | Lynne Pezzullo, Jared Streatfeild, Jackson Smith, Darren Mansfield, David R. Hillman |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Sleep Wake Disorders media_common.quotation_subject Population 030204 cardiovascular system & hematology Gross domestic product 03 medical and health sciences 0302 clinical medicine Cost of Illness Physiology (medical) Economic cost Environmental health Health care Insomnia medicine Deadweight loss Humans education Productivity media_common education.field_of_study business.industry Australia Health Care Costs Neurology (clinical) medicine.symptom Health Expenditures business Welfare 030217 neurology & neurosurgery |
| Zdroj: | Sleep. 44(11) |
| ISSN: | 1550-9109 |
| Popis: | Study Objectives To estimate economic cost of common sleep disorders in Australia for 2019–2020. Methods Costs were estimated for obstructive sleep apnea (OSA), insomnia, and restless legs syndrome (RLS) using prevalence, financial, and nonfinancial data from national databases. These included: (1) financial costs associated with health care, informal care, productivity losses, non-medical accident costs, deadweight loss from taxation/welfare inefficiencies; and (2) nonfinancial costs associated with loss of well-being. They were expressed in U.S. dollars ($). Results Estimated overall cost of sleep disorders in Australia in 2019–2020 (population: 25.5 million) was $35.4 billion (OSA $13.1 billion; insomnia $13.3 billion, RLS $9.0 billion). Of this, the financial cost component was $10.0 billion, comprised of: health system costs $0.7 billion; productivity losses $7.7 billion; informal care $0.2 billion; other, mainly non-medical accident costs, $0.4 billion; and deadweight losses $1.0 billion. For moderate to severe OSA syndrome, insomnia unrelated to other conditions and RLS, financial costs represented $16,717, $21,982, and $16,624 per adult with the condition for the year, respectively. The nonfinancial cost was $25.4 billion. Conclusions The economic costs associated with sleep disorders are substantial. The financial component of $10.0 billion is equivalent to 0.73% of Australian gross domestic product. The nonfinancial cost of $25.4 billion represents 3.2% of total Australian burden of disease for the year. Health system costs of these disorders are low relative to those associated with their consequences, suggesting greater expenditure on detection, treatment and prevention is warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|